The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,569,865 in first-year total cost, median $1,065,423.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JRR-A (J2)]3
Most frequent institutions
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Therapeutic vaccination and PD-1 blockade in treated HIV disease1U01AI131296-01 | DEEKS, STEVEN GRANT | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,491,834 | ZAI1 |
| 2017 | Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure1U01AI131285-01 | MACATANGAY, BERNARD JONAS CMELLORS, JOHN WRIDDLER, SHARON | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $1,065,423 | ZAI1 |
| 2017 | Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-11U01AI131310-01 | GOONETILLEKE, NILU | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,012,608 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.